What we found on the web about Hyperuricemia
Hyperuricemia - Wikipedia, the free encyclopedia
Hyperuricemia (British English: hyperuricaemia) is a level of uric acid in the blood that is abnormally high. In humans, the upper end of the normal range is 360 µmol/L (6 mg/dL ...
Lesch-Nyhan syndrome - Wikipedia, the free encyclopedia
The lack of HGPRT causes a build-up of uric acid in all body fluids: both hyperuricemia and hyperuricosuria, which lead to problems such as severe gout and kidney problems, poor ...
hyperuricemia: Definition from Answers.com
hyperuricemia n. Excess uric acid in the blood, as in gout. ... An excess of uric acid in the blood; found in Dalmatian dogs and selected strains of chickens.
[Hyperuricemia] [Pol Merkur Lekarski. 2005] - PubMed Result
PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to ...
Hyperuricemia: eMedicine Nephrology
Overview: Uric acid is the final product of purine metabolism in human beings. Despite the fact that uric acid was first identified approximately 2 centuries ago, certain ...
Asymptomatic hyperuricemia
INTRODUCTION Asymptomatic hyperuricemia is the term applied to settings in which the serum urate concentration is elevated, but neither symptoms nor signs of urate deposition have ...
Medscape Search
Hyperuricemia and Gout: New Clinical Insights and Emerging Treatments Review the clinical picture of hyperuricemia in gout and evaluate new treatments, such as rasburicase; uricase ...
Does Hyperuricemia Hurt? It Probably Will Sometime
Hyperuricemia causes gout. It's simply too much uric acid, but it's not always simple. Why does it happen? Why worry if it doesn't hurt? Managing hyperuricemia properly avoids long ...
Hyperuricemia | Gout & Uric Acid Education Society
The Gout & Uric Acid Education Society's Web site is designed to help gout sufferers enhance their understanding of the disease and its treatments, identify lifestyle modifications ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Hyperuricemia

Hyperuricemia ( ) is a level of uric acid in the blood that is abnormally high. In humans, the upper end of the normal range is 360 µmol/L (6 mg/dL) for women and 400 µmol/L (6.8 mg/dL) for men.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Hyperuricemia
FDA Approves First Gout Drug In 40 Years
Medical News Today
It is not recommended for asymptomatic hyperuricemia, said the company's press release. Febuxostat was discovered by another Japanese company, Teijin Pharma. Their president Osamu Nishikawa said in a press statement released jointly with Ta...
FDA Approves Gout-Fighting Drug for First Time in 4 Decades
Eflux Media
The Federal Drug Agency has approved the first gout drug in 40 years. Takeda Pharmaceuticals Co. has won the approval to sell Uloric in the United States. The drug is administered for the chronic management of hyperuricemia in gout patients...
Ardea Biosciences to Host Investor and Analyst Event
TradingMarkets.com
Ardea management will present results from its Phase 1 studies of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and Phase 2a study of RDEA806, RDEA594's prodrug, in patients with gout. Plans for the Phase ...
Ardea Biosciences Announces Investor and Analyst Event Participants ...
TradingMarkets.com
Ardea will present results from its recently completed Phase 1 studies of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and Phase 2a study of RDEA806, RDEA594's prodrug, in patients with gout. Plans for th...
Takeda Wins U.S. Approval for First New Gout Drug in 40 Years
Bloomberg
We are pleased to offer a new treatment option to the more than five million Americans who have hyperuricemia associated with gout.” Gout is a chronic condition marked by outbreaks of intense pain and swelling in the joints typically starti...
Ardea Biosciences Reports Recent Accomplishments and First Quarter ...
MSN MoneyCentral
Since our last quarterly update, we have reported positive clinical trial results for RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, and announced a global agreement with Bayer HealthCare focused ...
Takeda wins FDA approval for Uloric
The Money Times
We are pleased to offer a new treatment option, the first in 40 years, to the more than five million Americans who have hyperuricemia associated with gout, fulfilling an unmet need,” said Alan MacKenzie, president and CEO, Takeda Pharmaceut...
ULORIC(R) (febuxostat) 40-mg and 80-mg Tablets Now Available for the ...
PR Newswire
DEERFIELD, Ill., March 12 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. announced today that ULORIC(R) (febuxostat) is now available by prescription in pharmacies across the United States for the chronic management of hyperuric...
Ardea Biosciences (RDEA) Reports Positive Results from Phase 1 Study ...
StreetInsider.com
Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-co...
Japan Hot Stocks- Oil-linked shares, Pacific Golf, J-Oil Mills
Forbes
Takeda Pharmaceutical, Japan's largest drugmaker, rises 1 percent to 4,040 yen after the company said the U.S. Food and Drug Administration had approved its Uloric, a drug for the chronic management of hyperuricemia in patients with gout. 0...
Nikkei edges down after GDP, eyes on yen
Reuters
... 4502.T), Japan's largest drugmaker, was flat at 4,000 yen after shedding gains made in the wake of a company statement that the U.S. Food and Drug Administration had approved its Uloric, a drug for the chronic management of hyperuricem...